Survival, QOL, CV Event Rate No Better With Drug-Eluting Stents

This article originally appeared here.
Share this content:
Survival, QOL, CV Event Rate No Better With Drug-Eluting Stents
Survival, QOL, CV Event Rate No Better With Drug-Eluting Stents

WEDNESDAY, Aug. 31, 2016 (HealthDay News) -- Drug-eluting stents may perform no better for patients over the long-term, in terms of patient survival, than bare metal stents, according to a study published online Aug. 30 in the New England Journal of Medicine. The research was published to coincide with the annual European Society of Cardiology Congress, held from Aug. 27 to 31 in Rome.

Kaare Harald Bonaa, M.D., Ph.D., of the Norwegian University of Science and Technology in Trondheim, and colleagues tracked six-year outcomes for 9,013 patients. Patients received a stent after recurrent angina or a cardiovascular event such as a myocardial infarction.

Rates of revascularization procedures were low in each group: 16.5 percent in the drug-eluting stent group versus 19.8 percent in the bare-metal stent group. Patients who received a drug-eluting stent did have less need for a second revascularization procedure, but not to the level surgeons might have expected, Bonaa said. In fact, "thirty patients would need to be treated with drug-eluting stents rather than with bare-metal stents to prevent one repeat revascularization," he told HealthDay. The researchers found no significant difference between drug-eluting or bare-metal stents in either total patient deaths, nonfatal myocardial infarction, angina, or even patient quality of life.

Overall, "the take home message is that patients treated with drug-eluting stents do not live longer nor better than patients treated with bare-metal stents," Bonaa said.

Abstract
Full Text
Editorial
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Caffeine Found to Reduce Age-Related Inflammation

Caffeine Found to Reduce Age-Related Inflammation

Connection between advancing age, systemic inflammation, cardiovascular disease and caffeine

Neonatal Abstinence Syndrome Tied to Poor School Performance

Neonatal Abstinence Syndrome Tied to Poor School Performance

By seventh grade, four out of 10 failed to meet standards in at least one academic area

Heart Rate Variability Linked to Atrial Fibrillation

Heart Rate Variability Linked to Atrial Fibrillation

Lower HRV, increased sympathetic/parasympathetic tone linked to higher risk of a-fib

is free, fast, and customized just for you!

Already a member?

Sign In Now »